A common over-the-counter medication taken by more than 100 million people worldwide for urinary tract infections has been ...

A common over-the counter medication that’s been available for decades and is taken by millions worldwide has been singled ...

Shares of Spero Therapeutics gained after the company and GSK ended their trial for a treatment for complicated urinary tract infections early after it met its primary endpoint. The stock more than ...

Popular over-the-counter drugs used to treat uncomfortable urinary tract infections may come with a potential cancer risk.

Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract ...

British pharmaceutical company GSK PLC (GSK) and its Massachusetts-based partner Spero Therapeutics (SPRO) said on Wednesday ...

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...

GSK Plc halted a trial following positive results for an oral antibiotic to treat complicated urinary tract infections that could replace an intravenous medicine that is typically used.

GSK stopped a Phase 3 trial for its investigational oral treatment for complicated urinary tract infections following positive data. The U.K. pharma company said Wednesday that the decision to cancel ...

Case studies illustrate how embarrassment can prevent patients from seeking necessary medical help for foreign bodies lodged ...